← Back
$AVTX All transactions

Avalo Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$31K

Shares

1,780

Price

$18

Filed

Apr 3

Insider

Name

Sullivan Christopher Ryan

Title

Chief Financial Officer

CIK

0001810417

Roles

Officer

Transaction Details

Transaction Date

2026-04-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

17,338

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025. | The reported securities were sold in multiple transactions at prices ranging from $15.24 to $16.21. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. | The reported securities were sold in multiple transactions at prices ranging from $16.45 to $17.38. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. | The reported securities were sold in multiple transactions at prices ranging from $16.385 to $17.37. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. | The reported securities were sold in multiple transactions at prices ranging from $17.39 to $17.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Filing Info

Accession No.

0001810417-26-000006

Form Type

4

Issuer CIK

0001534120

Sullivan Christopher Ryan's History

Date Ticker Type Value
2026-04-02 AVTX $106K
2026-04-02 AVTX $31K
2026-04-01 AVTX $8K
2026-04-01 AVTX $126K
2026-03-28 AVTX M
2026-03-28 AVTX F $114K
2026-03-28 AVTX M $0

Other Insiders at AVTX (90d)

Insider Bought Sold Last
KAPLAN GILLA 2026-03-28
NEIL GARRY ARTHUR
Chief Executive Officer
2026-03-28
Lind Kevin Robert 2026-03-31
Jain Rita 2026-03-31
Chan Mitchell 2026-03-28
Sullivan Christopher Ryan
Chief Financial Officer
$239K 2026-04-02
KANTOFF AARON 2026-03-28
Doyle Mittie
Chief Medical Officer
$82K 2026-04-06
Goldman Jonathan 2026-03-28
Truex Samantha 2026-03-28